Novel Hormonal Combination Therapy for Triple Negative Breast Cancer | Semantic Scholar
CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells
Bicalutamide | SpringerLink
Mechanism of action of enzalutamide in the androgen receptor signaling... | Download Scientific Diagram
Mechanism of action of enzalutamide. Note: enzalutamide inhibits... | Download Scientific Diagram
Mechanisms of action of hormone-mediated prostate cancer therapies on... | Download Scientific Diagram
Bicalutamide - Wikipedia
Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer - ScienceDirect
Novel hormonal therapy for castration-resistant prostate cancer - Annals of Oncology
Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole | Prostate Cancer and Prostatic Diseases
Androgen receptor antagonists for prostate cancer therapy in: Endocrine-Related Cancer Volume 21 Issue 4 (2014)
Progress in the mechanism and drug development of castration-resistant prostate cancer | Future Medicinal Chemistry
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology
Androgen receptor antagonists for prostate cancer therapy in: Endocrine-Related Cancer Volume 21 Issue 4 (2014)
Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic - Imamura - 2016 - International Journal of Urology - Wiley Online Library
Male sex hormones Androgens Types: 1.Natural androgens: – Androsterone and testosterone 2.Synthetic androgens: – Testosterone propionate. – Anabolic. - ppt download
Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer - Schalken - 2016 - BJU International - Wiley Online Library
Bicalutamide - Wikipedia
Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer: Trends in Endocrinology & Metabolism
Bicalutmide
Scheme depicting the mechanism by which the combination of rapamycin... | Download Scientific Diagram
Bicalutamide | C18H14F4N2O4S - PubChem
Bicalutamide - an overview | ScienceDirect Topics
Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target - The Lancet Oncology
